Skip to main content

Fuse Biotherapeutics

Los Angeles, United States

Fuse Biotherapeutics is a biotech company developing next-generation immune-modulating therapeutics for patients with cancers.

$9.5M raised
Nov 2021
Seed

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Fuse Biotherapeutics

How much funding has Fuse Biotherapeutics raised?
Fuse Biotherapeutics has raised $9.5M in total funding. The most recent round was Seed. The last funding was announced in November 2021.
Who are Fuse Biotherapeutics's investors?
Fuse Biotherapeutics's investors include Sherpa Healthcare Partners, GC&H Investments, Sirona Capital, Viva BioInnovator, Ivy Venture Group.
Where is Fuse Biotherapeutics headquartered?
Fuse Biotherapeutics is headquartered in Los Angeles, United States.
What does Fuse Biotherapeutics do?
Fuse Biotherapeutics is a biotech company developing next-generation immune-modulating therapeutics for patients with cancers.
What stage is Fuse Biotherapeutics at?
Fuse Biotherapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Fuse Biotherapeutics — Funding & Investors." VCBacked, November 15, 2021, https://www.vcbacked.co/company/fuse-biotherapeutics. Accessed July 2, 2026.
APA
VCBacked. (2021). Fuse Biotherapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/fuse-biotherapeutics
Wikipedia (cite web)
{{cite web |title=Fuse Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/fuse-biotherapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .